According to Mordor Intelligence, the ventricular assist devices market size is valued at USD 1.88 billion in 2026, rising ...

This analysis evaluates the relationship between hospital care delivery network fragmentation and in-hospital and 90-day outcomes. These networks may be novel targets for improving outcomes.

Mechanical circulatory support systems for the treatment of end-stage heart failure are now available for a wide variety of clinical situations and support times. Extracorporeal membrane oxygenation ...

Just before a major heart surgery at Piedmont Augusta, Akira Joy Hendricks had one urgent request.

Ventricular assist devices are mechanical pumps that take over the function of the damaged ventricle in order to re-establish normal hemodynamics and end-organ blood flow. In addition, VADs unload the ...

Patients with cardiogenic shock treated at hospitals with a higher volume of percutaneous microaxial VAD implantation in the US have lower mortality risk. Higher hospital procedure volume of ...

Researchers from the University of South Florida developed a novel ventricular assist device that is placed directly inside a failing ventricular cavity to help it pump blood correctly again. This ...

Please provide your email address to receive an email when new articles are posted on . The FDA and Medtronic alerted health care providers to no longer implant patients with end-stage HF with a ...

According to Mordor Intelligence, the ventricular assist devices market size is valued at USD 1.88 billion in 2026, rising from USD 1.73 billion ...